Ticker brief
CRSP CRISPR THERAPEUTICS AG
Consumer, Non-cyclical · Biotechnology
last close
$57.72
1 day
-2.8%
14 days
+7.8%
mkt cap
$5.9B
signals 14d
31
authors 14d
21
crowd 14d
-0.2σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 68% rich · 81 pctile own 1y | IV/HV 1.48× (as of 2026-07-31) |
| Skew — 25Δ RR 30d | +0.050 84 pctile own 1y | calls bid vs puts (call skew rich) |
| Net dealer OI (NDOI) | +0.35 thin | 5-session Δ -0.87 (as of 2026-07-16) |
| OI alarm | quiet | last alarm 2025-07-22 (z=2.4) |
Sentiment — last 14 days
daily mean sentiment, 2026-08-16 → 2026-08-28 · now +0.20 (−1 bearish … +1 bullish)
Who spoke21
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @MisterInversor | C | +0.71 | 5 | +0.36 |
| @HeidingOut | C | -1.40 | 5 | +0.38 |
| @MinervaCap | C | -0.39 | 2 | +0.13 |
| @ShakePryzby1 | B | +0.06 | 2 | +0.20 |
| @ElysiumEffect | C | -0.84 | 1 | +0.65 |
| @alphacharts | B | -3.11 | 1 | +0.60 |
| @szaman | C | -2.05 | 1 | +0.20 |
| @TLAMB91 | C | +0.55 | 1 | +0.20 |
| @Blaine_Tarr | C | +0.03 | 1 | +0.55 |
| @beach_trades | C | -0.04 | 1 | +0.35 |
| @PolycarpFX | B | +1.12 | 1 | +0.00 |
| @hiddensmallcaps | B | -0.77 | 1 | +0.40 |
| @cfaryanoconnell | C | -1.48 | 1 | +0.85 |
| @HyenukChu | C | +0.97 | 1 | +0.10 |
| @Nice_Stock_ | C | -1.23 | 1 | +0.20 |
| @DidymusLevi | C | -1.62 | 1 | +0.35 |
| @SandmanMarkets | C | -2.91 | 1 | +0.65 |
| @Sir_Kory | C | -0.11 | 1 | +0.45 |
| @ArtofSpecuycky | B | +0.68 | 1 | +0.50 |
| @eugeniodeveze | C | +1.08 | 1 | +0.00 |
| @OzmosiHealth | C | · | 1 | +0.55 |
Recent signals30of 31 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-28 | @ShakePryzby1 | -0.15 | Recaps successful PLTR adds and small losses in three weaker setups while discussing risk discipline. | — | tweet ↗ |
| 2026-08-28 | @OzmosiHealth | +0.55 | Phase 1a data show deep, durable editing and triglyceride and LDL reductions. | — | tweet ↗ |
| 2026-08-26 | @MisterInversor | +0.05 | Characterizes CRSP as very high risk with substantial theoretical upside. | -2.5% | tweet ↗ |
| 2026-08-25 | @MinervaCap | +0.15 | Daily watchlist names top trades for tomorrow without explicit entry intent. | -5.2% | tweet ↗ |
| 2026-08-25 | @eugeniodeveze | +0.00 | CRSP is testing resistance without a stated outcome. | -5.2% | tweet ↗ |
| 2026-08-25 | @ArtofSpecuycky | +0.50 | Presents genomics as a major decade-long investment theme and lists representative stocks. | -5.2% | tweet ↗ |
| 2026-08-25 | @Sir_Kory | +0.45 | Frames gene editing as a large long-term market and compares four public platforms by maturity and risk. | -5.2% | tweet ↗ |
| 2026-08-25 | @HeidingOut | +0.10 | Flags hidden bearish divergence while hoping the bullish breakout continues. | -5.2% | tweet ↗ |
| 2026-08-25 | @SandmanMarkets | +0.65 | Expresses broad bullishness on biotech and names four especially attractive stocks. | -5.2% | tweet ↗ |
| 2026-08-25 | @DidymusLevi | +0.35 | Observes substantial capital positioning in biotech ETFs and stocks. | -5.2% | tweet ↗ |
| 2026-08-25 | @HeidingOut | +0.80 | Discloses an ABCL share entry and existing CRSP options across expiries. | -5.2% | tweet ↗ |
| 2026-08-24 | @Nice_Stock_ | +0.20 | Lists ARKG's leading portfolio weights and calls its holdings currently popular. | +1.1% | tweet ↗ |
| 2026-08-23 | @HyenukChu | +0.10 | Presents a genome-sector basket, but the accompanying image is needed for the underlying analysis. | -3.0% | tweet ↗ |
| 2026-08-23 | @MisterInversor | +0.40 | Frames longevity and curing disease as a major long-term investment theme. | -3.0% | tweet ↗ |
| 2026-08-21 | @HeidingOut | -0.35 | Expresses frustration that CRSP ruined a favorable chart setup. | -3.0% | tweet ↗ |
| 2026-08-21 | @cfaryanoconnell | +0.85 | Claims five biotech stocks could rise tenfold within five years. | -3.0% | tweet ↗ |
| 2026-08-21 | @hiddensmallcaps | +0.40 | Compares gene-editing basket valuations with IONQ to argue biotech sentiment has room to improve. | -3.0% | tweet ↗ |
| 2026-08-21 | @PolycarpFX | +0.00 | Flags a leading volume print but asks whether ARKG will rise or fall | -3.0% | tweet ↗ |
| 2026-08-21 | @beach_trades | +0.35 | Directs NTLA observers to CRSP's move, implying a favorable peer read-through. | -3.0% | tweet ↗ |
| 2026-08-21 | @ShakePryzby1 | +0.55 | Sees a potential biotech leadership cycle and highlights CRSP as a breakout candidate. | -3.0% | tweet ↗ |
| 2026-08-21 | @Blaine_Tarr | +0.55 | Discloses CRSP share ownership while suggesting the weekly chart may be ready to break out. | -3.0% | tweet ↗ |
| 2026-08-20 | @TLAMB91 | +0.20 | Sees substantial CRSP potential but says the current market environment is unfavorable. | -0.7% | tweet ↗ |
| 2026-08-19 | @MinervaCap | +0.10 | Lists tomorrow's top watchlist trades without specifying entries, stops or directional mechanics. | -3.5% | tweet ↗ |
| 2026-08-19 | @szaman | +0.20 | Places CRSP and TEM on a watchlist due to MRNA strength. | -3.5% | tweet ↗ |
| 2026-08-19 | @MisterInversor | +0.55 | Uses Moderna's 182% rise to express a multi-year bullish outlook for a healthcare basket. | -3.5% | tweet ↗ |
| 2026-08-19 | @HeidingOut | +0.70 | Projects CRSP to $195 after an eventual resistance breakout. | -3.5% | tweet ↗ |
| 2026-08-19 | @HeidingOut | +0.65 | Briefly expresses strong affection for CRSP. | -3.5% | tweet ↗ |
| 2026-08-19 | @MisterInversor | +0.40 | Reports TEM and CRSP surging on favorable sector news and IBRX rebounding. | -3.5% | tweet ↗ |
| 2026-08-19 | @alphacharts | +0.60 | Identifies a giant inverse head-and-shoulders base in CRSP. | -3.5% | tweet ↗ |
| 2026-08-18 | @ElysiumEffect | +0.65 | Long-horizon bullish thesis that AI will transform drug discovery and disease treatment. | +9.0% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.